Pancreatic Cancer Diagnostics - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Pancreatic Cancer Diagnostics Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Pancreatic Cancer Diagnostics Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Pancreatic Cancer Diagnostics Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Opportunities in early-stage detection technologies
- 3.1.2 partnerships with healthcare providers
-
3.2 Available Opportunities
- 3.2.1 Opportunities in early-stage detection technologies
-
3.3 Influencing Trends
- 3.3.1 Growth of non-invasive diagnostic methods
- 3.3.2 increasi
-
3.4 Challenges
- 3.4.1 Diagnostic complexity
- 3.4.2 limited public awareness
- 3.4.3 re
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Pancreatic Cancer Diagnostics Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Pancreatic Cancer Diagnostics Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Pancreatic Cancer Diagnostics : Competition Benchmarking & Performance Evaluation
- 5.1 Global Pancreatic Cancer Diagnostics Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Pancreatic Cancer Diagnostics Revenue 2019
- 5.3 Global Pancreatic Cancer Diagnostics Sales Volume by Manufacturers (2019)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 5C’s Analysis
- 5.6 Ansoff Matrix
Chapter 6: Global Pancreatic Cancer Diagnostics Market: Company Profiles
- 6.1 Roche (Switzerland) 2. Abbott Laboratories (USA) 3. Siemens Healthineers (Germany) 4. Thermo Fisher Scientific (USA) 5. Bio-Rad (USA) 6. Quest Diagnostics (USA) 7. Medtronic (Ireland) 8. Philips (Netherlands) 9. DiaSorin (Italy) 10. Myriad Genetics (USA) 11. Exact Sciences (USA) 12. Guardant Health (USA) 13. Foundation Medicine (USA) 14. CellMax Life (USA) 15. OncoOne (USA) 16. Bio-Techne (USA) 17. Caris Life Sciences (USA) 18. Axxess (USA) 19. Novo Nordisk (Denmark) 20. BD Diagnostics (USA)
- 6.1.1 Roche (Switzerland) 2. Abbott Laboratories (USA) 3. Siemens Healthineers (Germany) 4. Thermo Fisher Scientific (USA) 5. Bio-Rad (USA) 6. Quest Diagnostics (USA) 7. Medtronic (Ireland) 8. Philips (Netherlands) 9. DiaSorin (Italy) 10. Myriad Genetics (USA) 11. Exact Sciences (USA) 12. Guardant Health (USA) 13. Foundation Medicine (USA) 14. CellMax Life (USA) 15. OncoOne (USA) 16. Bio-Techne (USA) 17. Caris Life Sciences (USA) 18. Axxess (USA) 19. Novo Nordisk (Denmark) 20. BD Diagnostics (USA) Company Overview
- 6.1.2 Roche (Switzerland) 2. Abbott Laboratories (USA) 3. Siemens Healthineers (Germany) 4. Thermo Fisher Scientific (USA) 5. Bio-Rad (USA) 6. Quest Diagnostics (USA) 7. Medtronic (Ireland) 8. Philips (Netherlands) 9. DiaSorin (Italy) 10. Myriad Genetics (USA) 11. Exact Sciences (USA) 12. Guardant Health (USA) 13. Foundation Medicine (USA) 14. CellMax Life (USA) 15. OncoOne (USA) 16. Bio-Techne (USA) 17. Caris Life Sciences (USA) 18. Axxess (USA) 19. Novo Nordisk (Denmark) 20. BD Diagnostics (USA) Product/Service Portfolio & Specifications
- 6.1.3 Roche (Switzerland) 2. Abbott Laboratories (USA) 3. Siemens Healthineers (Germany) 4. Thermo Fisher Scientific (USA) 5. Bio-Rad (USA) 6. Quest Diagnostics (USA) 7. Medtronic (Ireland) 8. Philips (Netherlands) 9. DiaSorin (Italy) 10. Myriad Genetics (USA) 11. Exact Sciences (USA) 12. Guardant Health (USA) 13. Foundation Medicine (USA) 14. CellMax Life (USA) 15. OncoOne (USA) 16. Bio-Techne (USA) 17. Caris Life Sciences (USA) 18. Axxess (USA) 19. Novo Nordisk (Denmark) 20. BD Diagnostics (USA) Key Financial Metrics
- 6.1.4 Roche (Switzerland) 2. Abbott Laboratories (USA) 3. Siemens Healthineers (Germany) 4. Thermo Fisher Scientific (USA) 5. Bio-Rad (USA) 6. Quest Diagnostics (USA) 7. Medtronic (Ireland) 8. Philips (Netherlands) 9. DiaSorin (Italy) 10. Myriad Genetics (USA) 11. Exact Sciences (USA) 12. Guardant Health (USA) 13. Foundation Medicine (USA) 14. CellMax Life (USA) 15. OncoOne (USA) 16. Bio-Techne (USA) 17. Caris Life Sciences (USA) 18. Axxess (USA) 19. Novo Nordisk (Denmark) 20. BD Diagnostics (USA) SWOT Analysis
- 6.1.5 Roche (Switzerland) 2. Abbott Laboratories (USA) 3. Siemens Healthineers (Germany) 4. Thermo Fisher Scientific (USA) 5. Bio-Rad (USA) 6. Quest Diagnostics (USA) 7. Medtronic (Ireland) 8. Philips (Netherlands) 9. DiaSorin (Italy) 10. Myriad Genetics (USA) 11. Exact Sciences (USA) 12. Guardant Health (USA) 13. Foundation Medicine (USA) 14. CellMax Life (USA) 15. OncoOne (USA) 16. Bio-Techne (USA) 17. Caris Life Sciences (USA) 18. Axxess (USA) 19. Novo Nordisk (Denmark) 20. BD Diagnostics (USA) Development Activities
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Pancreatic Cancer Diagnostics by Type & Application (2024-2030)
-
7.1 Global Pancreatic Cancer Diagnostics Market Revenue Analysis (USD Million) by Type (2024-2019)
- 7.1.1 Imaging Techniques
- 7.1.2 Biomarker Testing
- 7.1.3 Genetic Testing
- 7.1.4 Liquid Biopsy
-
7.2 Global Pancreatic Cancer Diagnostics Market Revenue Analysis (USD Million) by Application (2024-2019)
- 7.2.1 Healthcare
- 7.2.2 Oncology
- 7.2.3 Personalized Medicine
-
7.3 Global Pancreatic Cancer Diagnostics Market Revenue Analysis (USD Million) by Type (2019-2030)
-
7.4 Global Pancreatic Cancer Diagnostics Market Revenue Analysis (USD Million) by Application (2019-2030)
Chapter 8 : North America Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 8.1 North America Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 8.2.1 Imaging Techniques
- 8.2.2 Biomarker Testing
- 8.2.3 Genetic Testing
- 8.2.4 Liquid Biopsy
-
8.3 North America Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 8.3.1 Healthcare
- 8.3.2 Oncology
- 8.3.3 Personalized Medicine
- 8.4 North America Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
8.5 North America Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
8.6 North America Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 9.1 LATAM Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 9.2.1 Imaging Techniques
- 9.2.2 Biomarker Testing
- 9.2.3 Genetic Testing
- 9.2.4 Liquid Biopsy
-
9.3 LATAM Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 9.3.1 Healthcare
- 9.3.2 Oncology
- 9.3.3 Personalized Medicine
- 9.4 LATAM Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
9.5 LATAM Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
9.6 LATAM Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 10 : West Europe Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 10.1 West Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 10.2.1 Imaging Techniques
- 10.2.2 Biomarker Testing
- 10.2.3 Genetic Testing
- 10.2.4 Liquid Biopsy
-
10.3 West Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 10.3.1 Healthcare
- 10.3.2 Oncology
- 10.3.3 Personalized Medicine
- 10.4 West Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
10.5 West Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
10.6 West Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 11 : Central & Eastern Europe Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 11.2.1 Imaging Techniques
- 11.2.2 Biomarker Testing
- 11.2.3 Genetic Testing
- 11.2.4 Liquid Biopsy
-
11.3 Central & Eastern Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 11.3.1 Healthcare
- 11.3.2 Oncology
- 11.3.3 Personalized Medicine
- 11.4 Central & Eastern Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
11.5 Central & Eastern Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
11.6 Central & Eastern Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 12 : Northern Europe Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 12.2.1 Imaging Techniques
- 12.2.2 Biomarker Testing
- 12.2.3 Genetic Testing
- 12.2.4 Liquid Biopsy
-
12.3 Northern Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 12.3.1 Healthcare
- 12.3.2 Oncology
- 12.3.3 Personalized Medicine
- 12.4 Northern Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
12.5 Northern Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
12.6 Northern Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 13 : Southern Europe Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 13.2.1 Imaging Techniques
- 13.2.2 Biomarker Testing
- 13.2.3 Genetic Testing
- 13.2.4 Liquid Biopsy
-
13.3 Southern Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 13.3.1 Healthcare
- 13.3.2 Oncology
- 13.3.3 Personalized Medicine
- 13.4 Southern Europe Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
13.5 Southern Europe Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
13.6 Southern Europe Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 14 : East Asia Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 14.1 East Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 14.2.1 Imaging Techniques
- 14.2.2 Biomarker Testing
- 14.2.3 Genetic Testing
- 14.2.4 Liquid Biopsy
-
14.3 East Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 14.3.1 Healthcare
- 14.3.2 Oncology
- 14.3.3 Personalized Medicine
- 14.4 East Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
14.5 East Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
14.6 East Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 15 : Southeast Asia Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 15.2.1 Imaging Techniques
- 15.2.2 Biomarker Testing
- 15.2.3 Genetic Testing
- 15.2.4 Liquid Biopsy
-
15.3 Southeast Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 15.3.1 Healthcare
- 15.3.2 Oncology
- 15.3.3 Personalized Medicine
- 15.4 Southeast Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
15.5 Southeast Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
15.6 Southeast Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 16 : South Asia Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 16.1 South Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 16.2.1 Imaging Techniques
- 16.2.2 Biomarker Testing
- 16.2.3 Genetic Testing
- 16.2.4 Liquid Biopsy
-
16.3 South Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 16.3.1 Healthcare
- 16.3.2 Oncology
- 16.3.3 Personalized Medicine
- 16.4 South Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
16.5 South Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
16.6 South Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 17 : Central Asia Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 17.1 Central Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 17.2.1 Imaging Techniques
- 17.2.2 Biomarker Testing
- 17.2.3 Genetic Testing
- 17.2.4 Liquid Biopsy
-
17.3 Central Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 17.3.1 Healthcare
- 17.3.2 Oncology
- 17.3.3 Personalized Medicine
- 17.4 Central Asia Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
17.5 Central Asia Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
17.6 Central Asia Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 18 : Oceania Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 18.1 Oceania Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 18.2.1 Imaging Techniques
- 18.2.2 Biomarker Testing
- 18.2.3 Genetic Testing
- 18.2.4 Liquid Biopsy
-
18.3 Oceania Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 18.3.1 Healthcare
- 18.3.2 Oncology
- 18.3.3 Personalized Medicine
- 18.4 Oceania Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
18.5 Oceania Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
18.6 Oceania Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 19 : MEA Pancreatic Cancer Diagnostics Market Breakdown by Country, Type & Application
- 19.1 MEA Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 19.2.1 Imaging Techniques
- 19.2.2 Biomarker Testing
- 19.2.3 Genetic Testing
- 19.2.4 Liquid Biopsy
-
19.3 MEA Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 19.3.1 Healthcare
- 19.3.2 Oncology
- 19.3.3 Personalized Medicine
- 19.4 MEA Pancreatic Cancer Diagnostics Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
-
19.5 MEA Pancreatic Cancer Diagnostics Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
-
19.6 MEA Pancreatic Cancer Diagnostics Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer